| N06AX18 |
Reboxetine |
Edronax |
Tablet |
4 |
mg |
20 |
Pfizer Europe MA EEIG, Обединено Кралство |
8 |
mg |
- |
19.52 |
0.98433 |
9.84 |
50% |
4.92 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-1071/26.07.2012 г.; НСР-2231/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
1357 |
|
| N06AX21 |
Duloxetine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N06AX21 |
Duloxetine |
Aritavi |
Gastro‐resistant capsule, hard |
30 |
mg |
28 |
Actavis Group PTC ehf., Исландия |
60 |
mg |
- |
42.64 |
1.42786 |
19.99 |
50% |
9.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-7496/13.11.2015. |
02.06.2016 |
|
|
Активен |
4098 |
31.98 |
| N06AX21 |
Duloxetine |
Aritavi |
Gastro‐resistant capsule, hard |
60 |
mg |
28 |
Actavis Group PTC ehf., Исландия |
60 |
mg |
- |
82.52 |
1.42786 |
39.98 |
50% |
19.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-7496/13.11.2015. |
02.06.2016 |
|
|
Активен |
4099 |
Без промяна |
| N06AX21 |
Duloxetine |
Dulasolan |
Gastro‐resistant capsule, hard |
60 |
mg |
30 |
G. L. Pharma GmbH, Австрия |
60 |
mg |
- |
88.37 |
1.42786 |
42.84 |
50% |
21.42 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-8042/08.02.2016. |
02.06.2016 |
|
|
Активен |
4181 |
Без промяна |
| N06AX21 |
Duloxetine |
Dulasolan |
Gastro‐resistant capsule, hard |
30 |
mg |
30 |
G. L. Pharma GmbH, Австрия |
60 |
mg |
- |
44.2 |
1.42786 |
21.42 |
50% |
10.71 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-8042/08.02.2016. |
02.06.2016 |
|
|
Активен |
4180 |
Без промяна |
| N06AX21 |
Duloxetine |
Dulodet |
Gastro‐resistant capsule, hard |
30 |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
60 |
mg |
- |
26.28 |
1.42786 |
19.99 |
50% |
9.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-8536/16.03.2016 |
02.06.2016 |
|
|
Активен |
4200 |
Без промяна |
| N06AX21 |
Duloxetine |
Duloxetine Alvogen |
Gastro‐resistant capsule, hard |
60 |
mg |
30 |
Alvogen IPCo S.àr.l, Люксембург |
60 |
mg |
- |
50.69 |
1.42786 |
42.84 |
50% |
21.42 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9108/27.04.2016. |
02.06.2016 |
|
|
Активен |
15017 |
Без промяна |
| N06AX21 |
Duloxetine |
Duloxetine Alvogen |
Gastro‐resistant capsule, hard |
30 |
mg |
30 |
Alvogen IPCo S.àr.l, Люксембург |
60 |
mg |
- |
29.1 |
1.42786 |
21.42 |
50% |
10.71 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9108/27.04.2016. |
02.06.2016 |
|
|
Активен |
15020 |
Без промяна |
| N06AX21 |
Duloxetine |
Duloxgamma |
Gastro‐resistant capsule, hard |
30 |
mg |
28 |
Woerwag Pharma GmbH & Co.KG, Германия |
60 |
mg |
- |
24.6 |
1.42786 |
19.99 |
50% |
9.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9125/27.04.2016. |
02.06.2016 |
|
|
Активен |
15027 |
Без промяна |
| N06AX21 |
Duloxetine |
Duloxgamma |
Gastro‐resistant capsule, hard |
60 |
mg |
28 |
Woerwag Pharma GmbH & Co.KG, Германия |
60 |
mg |
- |
39.98 |
1.42786 |
39.98 |
50% |
19.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9125/27.04.2016. |
02.06.2016 |
|
|
Активен |
15028 |
Без промяна |
| N06AX21 |
Duloxetine |
Dulsevia |
Gastro‐resistant capsule, hard |
30 |
mg |
28 |
KRKA, d.d., Словения |
60 |
mg |
- |
29.1 |
1.42786 |
19.99 |
50% |
9.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-7358/05.11.2015 |
02.06.2016 |
|
|
Активен |
4107 |
Без промяна |
| N06AX21 |
Duloxetine |
Dulsevia |
Gastro‐resistant capsule, hard |
60 |
mg |
28 |
KRKA, d.d., Словения |
60 |
mg |
- |
50.69 |
1.42786 |
39.98 |
50% |
19.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-7358/05.11.2015 |
02.06.2016 |
|
|
Активен |
4108 |
Без промяна |
| N06AX21 |
Duloxetine |
Duloxi |
Gastro‐resistant capsule, hard |
30 |
mg |
28 |
Фармаконс АД, България |
60 |
mg |
- |
44.64 |
1.42786 |
19.99 |
50% |
9.99 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9648/23.06.2016 |
42584 |
|
|
Активен |
15307 |
31.98 |
| N06AX21 |
Duloxetine |
Duloxi |
Gastro‐resistant capsule, hard |
60 |
mg |
30 |
Фармаконс АД, България |
60 |
mg |
- |
86.4 |
1.42786 |
42.84 |
50% |
21.42 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9805/14.07.2016 |
42584 |
|
|
Активен |
15298 |
Без промяна |
| N06AX22 |
Agomelatine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N06AX22 |
Agomelatine |
Valdoxan |
Film‐coated tablet |
25 |
mg |
28 |
Les Laboratoires Servier, Франция |
25 |
mg |
- |
84.18 |
3.00643 |
84.18 |
50% |
42.09 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№ 124/ 13.12.2010; КЦРР-2022/21.01.2013 г.;НСР-4941/22.10.2014 и КП-15/17.02.2015. |
16.03.2015 |
08.09.2012 |
|
Активен |
3614 |
Без промяна |
| N06BX03 |
Piracetam |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N06BX03 |
Piracetam |
Lucetam |
Film‐coated tablet |
1200 |
mg |
60 |
EGIS Pharmaceuticals PLC, Унгария |
2400 |
mg |
- |
10.38 |
0.346 |
10.38 |
25% |
2.6 |
|
F20.0,F20.1,F20.5,F20.6,F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4,G80.0,G80.1,G80.2,G80.3,G80.4,G80.8,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КП-74/25.11.2014; НСР-1515/25.10.2013 |
16.12.2014 |
08.09.2012 |
|
Активен |
3382 |
Без промяна |
| N06BX03 |
Piracetam |
Lucetam |
Film‐coated tablet |
800 |
mg |
60 |
EGIS Pharmaceuticals PLC, Унгария |
2400 |
mg |
- |
13.54 |
0.346 |
6.92 |
25% |
1.73 |
|
F20.0,F20.1,F20.5,F20.6,F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4,G80.0,G80.1,G80.2,G80.3,G80.4,G80.8,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
|
16.12.2014 |
08.09.2012 |
|
Активен |
379 |
11.07 |
| N06BX03 |
Piracetam |
Lucetam |
Film‐coated tablet |
800 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
2400 |
mg |
- |
4.58 |
0.40433 |
4.04 |
25% |
1.01 |
|
F20.0,F20.1,F20.5,F20.6,F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4,G80,I69 |
НСР-1238/23.09.2013 |
16.10.2013 |
08.09.2012 |
|
Заличен |
378 |
|
| N06BX03 |
Piracetam |
Lucetam |
Film‐coated tablet |
1200 |
mg |
20 |
EGIS Pharmaceuticals PLC, Унгария |
2400 |
mg |
- |
4.62 |
0.40433 |
4.04 |
25% |
1.01 |
|
F20.0,F20.1,F20.5,F20.6,F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4,G80,I69 |
НСР-1238/23.09.2013 |
16.10.2013 |
08.09.2012 |
|
Заличен |
377 |
|
| N06BX03 |
Piracetam |
Nootropil |
Film‐coated tablet |
800 |
mg |
30 |
UCB Pharma SA, Белгия |
2400 |
mg |
- |
12.5 |
0.346 |
3.46 |
25% |
0.87 |
|
F20.0,F20.1,F20.5,F20.6,F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4,G80.0,G80.1,G80.2,G80.3,G80.4,G80.8,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№20/15,07,2009 г.; КЦРР-627/18.05.2012 г. |
16.12.2014 |
08.09.2012 |
|
Активен |
1218 |
5.54 |
| N06BX03 |
Piracetam |
Nootropil |
Film‐coated tablet |
1200 |
mg |
20 |
UCB Pharma SA, Белгия |
2400 |
mg |
- |
6.73 |
0.346 |
3.46 |
25% |
0.87 |
|
F20.0,F20.1,F20.5,F20.6,F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4,G80.0,G80.1,G80.2,G80.3,G80.4,G80.8,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№20/15,07,2009 г. |
16.12.2014 |
08.09.2012 |
|
Активен |
505 |
5.54 |
| N06BX03 |
Piracetam |
Piracebral |
Film‐coated tablet |
800 |
mg |
30 |
Hexal AG, Германия |
2400 |
mg |
- |
7.45 |
0.346 |
3.46 |
25% |
0.87 |
|
F20.0,F20.1,F20.5,F20.6,F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4,G80.0,G80.1,G80.2,G80.3,G80.4,G80.8,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КЦРР-2241/08.02.2013 г.; НСР-7880/25.01.2016. |
02.03.2016 |
|
|
Заличен |
1620 |
|